We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-11.87%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$221B
AUM Growth
-$31.8B
Cap. Flow
+$2.77B
Cap. Flow %
1.26%
Top 10 Hldgs %
15.08%
Holding
8,767
New
731
Increased
3,710
Reduced
3,260
Closed
648

Sector Composition

Rank Sector Weight
1 Technology 8.03%
2 Financials 6.64%
3 Healthcare 6.26%
4 Consumer Discretionary 5.11%
5 Industrials 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITUB icon
7201
CALL
Itaú Unibanco
ITUB
$93.2B
$10K ﹤0.01%
1,512
-340,490
-100% -$2.19M
LPRO
7202
DELISTED
Open Lending Corp
LPRO
$10K ﹤0.01%
+1,000
New +$9.75K
LSTA icon
7203
Lisata Therapeutics
LSTA
$9.02M
$10K ﹤0.01%
181
+180
+18,000% +$12.5K
MRUS
7204
DELISTED
Merus
MRUS
$10K ﹤0.01%
681
+30
+5% +$434
PLYM
7205
DELISTED
Plymouth Industrial REIT
PLYM
$10K ﹤0.01%
828
-166
-17% -$2.2K
RCON icon
7206
Recon Technology
RCON
$39.7M
$10K ﹤0.01%
164
+102
+165% +$9.28K
REPL icon
7207
Replimune Group
REPL
$941M
$10K ﹤0.01%
1,000
-778
-44% -$10.5K
RFEM icon
7208
First Trust RiverFront Dynamic Emerging Markets ETF
RFEM
$78.3M
$10K ﹤0.01%
181
+99
+121% +$5.69K
FLNA
7209
Filana Therapeutics
FLNA
$48.8M
$10K ﹤0.01%
11,079
+4,931
+80% +$5.67K
TENX icon
7210
Tenax Therapeutics
TENX
$363M
$10K ﹤0.01%
5
+4
+400% +$22K
TOPS icon
7211
TOP Ships
TOPS
$3.49M
0
WHLR
7212
Wheeler Real Estate Investment Trust
WHLR
$549K
0
GPUS
7213
Hyperscale Data Inc
GPUS
$55.4M
0
VIRX
7214
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$10K ﹤0.01%
646
-202
-24% -$8.24K
DXYN
7215
DELISTED
Dixie Group Inc
DXYN
$10K ﹤0.01%
14,507
+13,884
+2,229% +$17.4K
VST.WS.A
7216
DELISTED
Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024)
VST.WS.A
$10K ﹤0.01%
7,447
+303
+4% +$479
CTG
7217
DELISTED
Computer Task Group, Inc.
CTG
$10K ﹤0.01%
2,429
+1,129
+87% +$5.18K
JHAA
7218
DELISTED
Nuveen Corporate Income 2023 Target Term Fund
JHAA
$10K ﹤0.01%
+940
New +$9.74K
UNVR
7219
DELISTED
Univar Solutions Inc.
UNVR
$10K ﹤0.01%
559
BDR
7220
DELISTED
Blonder Tongue Laboratories Inc
BDR
$10K ﹤0.01%
9,049
+9,000
+18,367% +$9.87K
DIVA
7221
DELISTED
AGFiQ Hedged Dividend Income Fund
DIVA
$10K ﹤0.01%
+443
New +$10.6K
CPTAG
7222
DELISTED
Capitala Finance Corp. 5.75% Convertible Notes Due 2022
CPTAG
$10K ﹤0.01%
400
LBJ
7223
DELISTED
Direxion Daily Latin America Bull 2X Shares
LBJ
$10K ﹤0.01%
+26
New +$11.6K
SYNC
7224
DELISTED
Synacor, Inc.
SYNC
$10K ﹤0.01%
6,605
+3,127
+90% +$5.51K
EIDX
7225
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$10K ﹤0.01%
735
-972
-57% -$12.3K

Similar funds

UBS Group's Q4 2018 Portfolio in Review

As of Q4 2018, UBS Group held 8,767 positions worth $221B, down 13% from $252B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group's Q4 2018 filing shows 731 new, 3,710 increased, 3,260 reduced and 648 closed positions. Its largest new stake was Linde: 4,971,408 shares worth $776M. The largest sale was Energy Transfer Partners, L.P., an estimated $1.06B.

By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 9.3% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2018 buy was Linde: 4,971,408 shares worth $776M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.82B increase.
  • UBS Group's biggest Q4 2018 reduction was Colgate-Palmolive, cutting an estimated $665M.
  • UBS Group fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.06B.
  • UBS Group's ten largest holdings make up 15% of its $221B portfolio in Q4 2018.
  • UBS Group opened 731 new positions and closed 648 in Q4 2018.
  • UBS Group's portfolio value fell 13% quarter-over-quarter to $221B.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.